AU5763786A - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
AU5763786A
AU5763786A AU57637/86A AU5763786A AU5763786A AU 5763786 A AU5763786 A AU 5763786A AU 57637/86 A AU57637/86 A AU 57637/86A AU 5763786 A AU5763786 A AU 5763786A AU 5763786 A AU5763786 A AU 5763786A
Authority
AU
Australia
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU57637/86A
Other versions
AU594954B2 (en
Inventor
Laszlo Revesz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU5763786A publication Critical patent/AU5763786A/en
Application granted granted Critical
Publication of AU594954B2 publication Critical patent/AU594954B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU57637/86A 1985-05-23 1986-05-21 Improvements in or relating to organic compounds Expired - Fee Related AU594954B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3518525 1985-05-23
DE3518525 1985-05-23

Publications (2)

Publication Number Publication Date
AU5763786A true AU5763786A (en) 1986-11-27
AU594954B2 AU594954B2 (en) 1990-03-22

Family

ID=6271435

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57637/86A Expired - Fee Related AU594954B2 (en) 1985-05-23 1986-05-21 Improvements in or relating to organic compounds

Country Status (18)

Country Link
JP (1) JPS61271275A (en)
AU (1) AU594954B2 (en)
BE (1) BE904796A (en)
DK (1) DK240386A (en)
ES (1) ES8802318A1 (en)
FI (1) FI862124A (en)
FR (1) FR2582309B1 (en)
GB (1) GB2175898B (en)
GR (1) GR861318B (en)
HU (1) HU196376B (en)
IL (1) IL78872A0 (en)
IT (1) IT1203791B (en)
LU (1) LU86435A1 (en)
NL (1) NL8601188A (en)
NZ (1) NZ216250A (en)
PH (1) PH23341A (en)
SE (1) SE8602308L (en)
ZA (1) ZA863873B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639053B2 (en) * 1989-11-28 1993-07-15 Toray Industries, Inc. Immunosuppressant and process for preparing the same
AU686203B2 (en) * 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
ATE172201T1 (en) * 1992-01-23 1998-10-15 Toray Industries MORPHINANE DERIVATIVES AND MEDICAL USES
CA2144770C (en) * 1993-07-19 2006-02-28 Hiroshi Nagase Brain cell protective agent
KR19990077125A (en) * 1996-01-10 1999-10-25 파올로 비지, 엔리꼬 카쭐라니 The heterocyclic-condensed morphine derivative (II)
DE69728585T2 (en) * 1996-11-25 2004-08-05 Toray Industries, Inc. Antipruritic agent
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
CA2486157C (en) 2002-05-17 2013-04-16 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4957489B2 (en) * 2002-10-09 2012-06-20 東レ株式会社 Pharmaceutical containing morphinan derivative having nitrogen-containing cyclic substituent or pharmacologically acceptable acid addition salt thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CA2714331C (en) 2008-02-14 2016-08-09 Alkermes, Inc. Selective opioid compounds
CA2894967A1 (en) * 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
JP6100917B2 (en) * 2012-12-14 2017-03-22 パーデュー、ファーマ、リミテッド、パートナーシップ Biological activity on pyridone morphinan analogues and opioid receptors.
AR096851A1 (en) * 2013-07-11 2016-02-03 H Lundbeck As SALTS THAT DO NOT FORM HYDRATS OR SOLVATOS DE NALMEFENO
EP3154972A4 (en) * 2014-06-13 2017-11-22 Purdue Pharma L.P. Azamophinan derivatives and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639053B2 (en) * 1989-11-28 1993-07-15 Toray Industries, Inc. Immunosuppressant and process for preparing the same
AU686203B2 (en) * 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use

Also Published As

Publication number Publication date
DK240386D0 (en) 1986-05-22
DK240386A (en) 1986-11-24
GB2175898A (en) 1986-12-10
GB2175898B (en) 1989-07-05
IT8648050A0 (en) 1986-05-23
LU86435A1 (en) 1986-12-05
HUT41737A (en) 1987-05-28
ZA863873B (en) 1988-01-27
GB8612159D0 (en) 1986-06-25
ES555200A0 (en) 1988-05-01
FR2582309A1 (en) 1986-11-28
IT1203791B (en) 1989-02-23
BE904796A (en) 1986-11-21
GR861318B (en) 1986-09-19
SE8602308D0 (en) 1986-05-21
FI862124A0 (en) 1986-05-21
SE8602308L (en) 1986-11-24
AU594954B2 (en) 1990-03-22
HU196376B (en) 1988-11-28
IL78872A0 (en) 1986-09-30
JPS61271275A (en) 1986-12-01
FI862124A (en) 1986-11-24
FR2582309B1 (en) 1989-08-18
ES8802318A1 (en) 1988-05-01
NZ216250A (en) 1990-04-26
NL8601188A (en) 1986-12-16
PH23341A (en) 1989-07-14

Similar Documents

Publication Publication Date Title
AU1892088A (en) Improvements in or relating to organic compounds
AU2490288A (en) Improvements in or relating to organic compounds
AU4140089A (en) Improvements in or relating to organic compounds
AU4587189A (en) Improvements in or relating to organic compounds
AU591890B2 (en) Improvements in or relating to 3-Aryluracils
AU3263789A (en) Improvements in or relating to organic compounds
AU2103588A (en) Improvements in or relating to organic compounds
AU5763786A (en) Improvements in or relating to organic compounds
AU2417588A (en) Improvements in or relating to organic compounds
AU7952682A (en) Improvements in or relating to organic compounds
AU1889388A (en) Improvements in or relating to organic compounds
AU7558787A (en) Improvements in or relating to organic compounds
GB9007514D0 (en) Improvements in or relating to organic compounds
AU1840988A (en) Improvements in or relating to organic compounds
AU3901789A (en) Improvements in or relating to organic compounds
AU5931386A (en) Improvements in or relating to organic compounds
GB8808411D0 (en) Improvements in/relating to organic compounds
AU3131389A (en) Improvements in or relating to organic compounds
AU8057587A (en) Improvements in or relating to organic compounds
AU6314090A (en) Improvements in or relating to organic compounds
AU4453589A (en) Improvements in or relating to organic compounds
GB2154605B (en) Improvements in or relating to organic compounds
AU5379286A (en) Improvements in or relating to organic compounds
AU586621B2 (en) Improvements in or relating to organic compounds
AU5060190A (en) Improvements in or relating to organic compounds